Adamis Pharmaceuticals (ADMP) Defended at Maxim
Tweet
Share
E-mailGet Alerts ADMP Hot Sheet
Price: $0.78 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 34
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 34
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy maintains Buy on Adamis Pharmaceuticals (NASDAQ: ADMP) price target of $13.00.
The analyst defends the name and believes the selloff is a buying opportunity.
For an analyst ratings summary and ratings history on Adamis Pharmaceuticals click here. For more ratings news on Adamis Pharmaceuticals click here.
Shares of Adamis Pharmaceuticals closed at $3.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baker Hughes (BKR) PT Lowered to $71 at UBS on Uncertainty Around GTLS
- Boston Scientific (BSX) PT Lowered to $74 at UBS as Shares Near 5-Year Lows
- TKO Group Holdings (TKO) PT Lowered to $235 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
